ArticleClinical and translational medicine2021

Large-scale genomic sequencing reveals adaptive opportunity of targeting mutated-PI3Kα in early and advanced HER2-positive breast cancer.

Lin-Wei Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.